Antidepressant utilization in Canada

Social Psychiatry and Psychiatric Epidemiology

Volumn 40, Issue 10, 2005, Pages 799-807

  Beck, Cynthia A ^a,b,c   Patten, Scott B ^a,b   Williams, Jeanne V A ^b   Wang, Jian Li ^a,b   Currie, Shawn R ^a   Maxwell, Colleen J ^b   El Guebaly, Nady ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

Antidepressive agents; Canada; Drug utilization; Epidemiology; Health surveys; Major depressive disorder

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CANADA; CONTROLLED STUDY; DEMOGRAPHY; DRUG INDICATION; DRUG USE; DRUG UTILIZATION; FEMALE; FIBROMYALGIA; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MENTAL HEALTH; MIGRAINE; PREVALENCE; SOCIAL ASPECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CANADA; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 27744608323     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-005-0968-0     Document Type: Article

References (41)

1. Wulsin LR, Vaillant GE, Wells VE (1999) A systematic review of the mortality of depression. Psychosom Med 61:6-17
2. Jacobs DG (1995) National Depression Screening Day: Educating the public, reaching those in need of treatment, and broadening professional understanding. Harv Rev Psychiatry 3:156-159
3. Hickie IB, Davenport TA, Naismith SL, Scott EM (2001) SPHERE: A national depression project. SPHERE National Secretariat. Med J Aust 175(Suppl):S4-S5
4. Katon W, Von Korff M, Lin E, Unutzer J, Simon G, Walker E, Ludman E, Bush T (1997) Population-based care of depression: Effective disease management strategies to decrease prevalence. Gen Hosp Psych 19:169-178
5. Paykel ES, Tylee A, Wright A, Priest RG, Rix S, Hart D (1997) The Defeat Depression Campaign: Psychiatry in the public arena. Am J Psychiatr 154:59-65
6. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P et al (2004) Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 291:2581-2590
7. Laukkala T, Isometsa E, Hamalainen J, Heikkinen M, Lindeman S, Aro H (2001) Antidepressant treatment of depression in the Finnish general population. Am J Psychiatr 158:2077-2079
8. Young AS, Klap R, Sherbourne CD, Wells KB (2001) The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 58:55-61
9. Patten SB, Beck C (2004) Major depression and mental health care utilization in Canada: 1994 to 2000. Can J Psychiatry 49:303-309
10. Keller MB, Hanks DL (1994) The natural history and heterogeneity of depressive disorders: Implications for rational antidepressant therapy. J Clin Psychiatry 55(Suppl A):25-31
11. Patten SB, Beck CA (2003) Underuse of antidepressants. Am J Psychiatr 160:189-190
12. Beck CA, Patten SB (2004) Adjustment to antidepressant utilization rates to account for depression in remission. Compr Psychiatry 45:268-274
13. American Psychiatric Association (2000) Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatr 157:1-45
14. Statistics Canada. Canadian Community Health Survey: Mental Health and Well-being; Catalogue no. 82-617-XIE. http://www.statcan.ca/english/ freepub/82-617-XIE/index.htm. Modified 9 Sep 2004. Cited 10 Jun 2005
15. Statistics Canada. Electronic communication regarding Canadian Community Health Survey. Statistics Canada. 8 Sep 2003
16. Kessler RC, Ustun TB (2004) The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 13:93-121
17. Wittchen HU (1994) Reliability and validity studies of the WHO - Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res 28:57-84
18. Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, Howes MJ, Jin R, Vega WA, Walters EE et al (2004) Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI). Int J Methods Psychiatr Res 13:122-139
19. RL Spitzer JB Williams M Gibbon MB First 1990 User's guide for the structured clinical interview for DSM-IIIR American Psychiatric Washington, DC
20. The SAS Institute 2004 The SAS system for Windows The SAS Institute Cary, NC
21. R Gravel 2002 Canadian community health survey: Mental health and well-being, public use microdata file guide (82M0021GPE) Statistics Canada Ottawa
22. Statistics Canada. Canadian community health survey mental health and well-being Cycle 1.2 Master File Documentation. http://www.statcan.ca/ english/sdds/document/5015_D4_T1_V1_E.pdf. Modified 13 May 2005. Cited 12 Jun 2005
23. JM Last 2001 A dictionary of epidemiology Oxford University Press New York
24. Kennedy SH, Lam RW, Cohen NL, Ravindran AV (2001) Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry 46(Suppl 1):38S-58S
25. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, Girolamo G, Graaf R, Demyttenaere K, Gasquet I et al (2004) Psychotropic drug utilization in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 55-64
26. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, Girolamo G, Graaf R, Demyttenaere K, Gasquet I et al (2004) Prevalence of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 21-27
27. Katz SJ, Kessler RC, Lin E, Wells KB (1998) Medication management of depression in the United States and Ontario. J Gen Intern Med 13:77-85
28. Kessler RC, Chiu WT, Demler O, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617-627
29. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095-3105
30. Brugha TS, Jenkins R, Taub N, Meltzer H, Bebbington PE (2001) A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol Med 31:1001-1013
31. Andrews G, Anstey K, Brodaty H, Issakidis C, Luscombe G (1999) Recall of depressive episode 25 years previously. Psychol Med 29:787-791
32. Patten SB, Sedmak B, Russell ML (2001) Major depression: Prevalence, treatment utilization and age in Canada. Can J Clin Pharmacol 8:133-138
33. Lam RW, Kennedy SH (2004) CPA position statement. Prescribing antidepressants for depression in 2005: Recent concerns and recommendations. Can J Psychiatr 49:I1-I12
34. Harlow SD, Linet MS (1989) Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol 129:233-248
35. Brown JB, Adams ME (1992) Patients as reliable reporters of medical care process. Recall of ambulatory encounter events. Med Care 30:400-411
36. Martin LM, Leff M, Calonge N, Garrett C, Nelson DE (2000) Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 18:215-218
37. King ES, Rimer BK, Trock B, Balshem A, Engstrom P (1990) How valid are mammography self-reports? Am J Public Health 80:1386-1388
38. Zapka JG, Bigelow C, Hurley T, Ford LD, Egelhofer J, Cloud WM, Sachsse E (1996) Mammography use among sociodemographically diverse women: The accuracy of self-report. Am J Public Health 86:1016-1021
39. Caplan LS, Mandelson MT, Anderson LA (2003) Validity of self-reported mammography: Examining recall and covariates among older women in a Health Maintenance Organization. Am J Epidemiol 157:267-272
40. Kwon A, Bungay KM, Pei Y, Rogers WH, Wilson IB, Zhou Q, Adler DA (2003) Antidepressant use: Concordance between self-report and claims records. Med Care 41:368-374
41. Statistics Canada Health Statistics Division 1997 National Population Health Survey 1996-97 Household Component User's Guide for the Public Use Microdata Files (82M0009GPE) Minister of Industry Ottawa